CANCER STATISTICS

Column

Key statistics (Pancreas, ICD-10: C25)

Male Female
Cancer incidence 2019–2023
Average number of new cases per year 688 681
Age-standardised incidence per 100 000 persons per year 24.8 19.4
Proportion of all cancers 3.5% 3.8%
Risk of developing cancer during lifetime 2.0% 2.1%
Average annual change in years 2014–2023 -0.7% -1.5%
Cancer mortality 2019–2023
Average number of deaths per year 631 651
Age-standardised mortality per 100 000 persons per year 22.9 18.3
Proportion of all cancer deaths 8.8% 10.6%
Risk of dying from cancer during lifetime 2.0% 2.1%
Average annual change in years 2014–2023 0.2% 0.1%
Cancer prevalence at the end of 2023
Number of people living with cancer diagnosis 857 883
Number of people living with cancer per 100 000 persons 30.9 31.2
Relative survival 2019–2023
One year after diagnosis 27% 30%
Five years after diagnosis 7% 8%

Column

Age-specific cancer incidence and mortality 2019–2023

Cancer incidence and mortality in 1953–2023 (age-standardised)

Cancer survival in 1959–2023 (age-standardised)

Column

How to interpret the table and figures? (Pancreas)

Cancer incidence in 2019–2023

  • On average 688 men and 681 women were diagnosed with cancer each year
    • 3.5% and 3.8% of all new cancer cases in men and women, respectively
    • relative to population, 24.8 in 100,000 men and 19.4 in 100,000 women were diagnosed with cancer each year (if the population’s age structure corresponded to Finland’s age structure in 2014).
  • The risk of developing cancer was highest in men aged 85 and over (see top figure)
    • 136 in 100,000 men developed cancer each year
    • In the female population of the same age, 121 in 100,000 women developed cancer each year
  • 2.0% of men and 2.1% of women develop cancer during their lifetime. This calculated estimate is based on the cancer incidence in 2019–2023.
  • Over the last ten years, 2014–2023, the average risk of cancer
    • did not change statistically significantly in men
    • decreased by 1.5% per year in women

Cancer mortality in 2019–2023

  • On average, 631 men and 651 women died from cancer each year
    • 8.8% and 10.6% of all cancer deaths in men and women, respectively
  • The risk of dying from cancer was highest in men aged 85 and over (see top figure)
    • 143 in 100,000 men died from cancer each year
    • In the female population of the same age, 128 in 100,000 women died from cancer each year
  • 2.0% of men and 2.1% of women die from cancer during their lifetime. This calculated estimate is based on the cancer mortality in 2019–2023.
  • Over the last ten years, 2014–2023, the average risk of dying from cancer
    • did not change statistically significantly in men
    • did not change statistically significantly in women

Number of people living with breast cancer at the end of 2023

  • 857 men and 883 women diagnosed with cancer were alive
    • 0,0% of men and 0.0% of women in Finland

Patient survival in 2019–2023

  • The average survival of patients was
    • 27% in men and 30% in women one year after diagnosis
    • 7% in men and 8% in women five years after diagnosis

Learn more about cancer diseases on the website All about cancer.

CONCEPTS

Column

Terms and definitions used in the cancer statistics
Cancer incidence The number of new cancer cases over a specific period of time (e.g. one calendar year) in the population. The incidence ratio is the number of cases per 100,000 persons per year. It is the number of new cases age-standardised to Finland’s age structure in 2014, i.e. in relation to the population, if the age structure of the population corresponded to the age structure in Finland in 2014. Gender differences or temporal changes in the age structure do not influence age-standardised incidence.
Cancer mortality The number of deaths attributable to cancer over a specific period of time in the population. The mortality ratio is the number of deaths per 100,000 persons per year. It is the number of cancer deaths age-standardised to Finland’s age structure in 2014, i.e. in relation to the population, if the age structure of the population corresponded to the age structure in Finland in 2014. Gender differences or temporal changes in the age structure do not influence age-standardised mortality.
Ten-year development in incidence and mortality Changes in the incidence and mortality of cancer were examined by comparing the average incidence and mortality rates per age group over the last ten years. The change percentage describes the average annual change in incidence and mortality rates per age group relative to the population. For example, a change percentage in incidence of +2% means an annual increase of 2 per cent, whereas –2% means an annual decrease of 2 per cent in age-standardised incidence.
People living with cancer (prevalence) The number of people living with cancer in the population at the end of 2023. The prevalence proportion is the corresponding number in relation to the population.
Patient survival The average survival of patients is measured by a relative survival ratio. It is an estimate of the proportion of patients who are alive after a certain period of time after diagnosis, if the cancer were the only factor affecting the mortality. The time series for patient survival has been age-standardised to the age distribution of patients diagnosed in Finland between 2019 and 2023, so that changes in the age structure do not affect the time series.